Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells (Q38855577)

7 September 2017

title

Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells (English)

1 reference

embryonal rhabdomyosarcoma

7 September 2017

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Angelo Sidoni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Rosario Francesco Donato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Sara Beccafico

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Giulio Morozzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Maria Cristina Marchetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Guglielmo Sorci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

7 July 2015

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

1071-1083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of impaired differentiation in rhabdomyosarcoma

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Classification of rhabdomyosarcoma and its molecular basis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Pax7 and myogenic progression in skeletal muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Targets for cancer therapy in childhood sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Artemisinin: discovery from the Chinese herbal garden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Development of artemisinin compounds for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Analysis of apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Histone phosphorylation: a chromatin modification involved in diverse nuclear events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Myogenic factors that regulate expression of muscle-specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

MicroRNAs flex their muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

MicroRNA control of muscle development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Treatment for childhood rhabdomyosarcoma: the cost of cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

The DNA damage response: putting checkpoints in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

MicroRNA expression signature of human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Muscle-specific microRNA miR-206 promotes muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

Effect of human colorectal carcinogenesis on the neural cell adhesion molecule expression and polysialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV098

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGV098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153023%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference